Drugmakers Seek Review of Intervention in HHS Rebate Pilot Suit

Major drugmakers are asking a federal appeals court to reverse an order that denied them from intervening in a case now closed between hospitals groups and the US government over a federal drug rebate pilot program.

The request from AbbVie Inc., AstraZeneca Plc, Boehringer Ingelheim Pharmaceuticals Inc., Novo Nordisk A/S, and the Pharmaceutical Research and Manufacturers of America asks the US Court of Appeals for the First Circuit to hear why they should have intervened in a case brought by the American Hospital Association against the Department of Health and Human Services’ 340B Rebate Model Pilot ...